Progresses on radiotherapy in pancreatic cancer
10.3760/cma.j.issn.1673-422X.2010.10.017
- VernacularTitle:胰腺癌放疗研究进展
- Author:
Ke LU
- Publication Type:Journal Article
- Keywords:
Pancreatic neoplasms;
Radiotherapy
- From:
Journal of International Oncology
2010;37(10):771-773
- CountryChina
- Language:Chinese
-
Abstract:
Recent researches have shown that resectable pancreatic cancer can benefit from post-operative adjuvant chemoradiation, regardless its surgical margins, tumor size, lymph node involvement and the level of cell differentiation. Several phase Ⅱ clinical trials indicated a good tolerance to preoperative chemoradiation. Although there is no gold standard for treating locally advanced unresectable pancreatic cancer, gemcitabine-based chemotherapy or chemoradiation therapy can increase survival rate compared with best supportive care.
